Arexvy
Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted · KIT · GlaxoSmithKline Biologicals SA
Arexvy is a kit containing respiratory syncytial virus vaccine recombinant, adjuvanted. Manufactured by GlaxoSmithKline Biologicals SA.
Key Facts
- Brand Name
- Arexvy
- Generic Name
- Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted
- NDC Code (Product)
58160-894- Manufacturer
- GlaxoSmithKline Biologicals SA
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125775
- Marketing Start
- 04/30/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is Arexvy used for?
Arexvy contains Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted. It is a kit taken as directed. Consult your doctor for specific uses.
Is Arexvy a controlled substance?
Arexvy is not classified as a controlled substance by the DEA.
What is the generic name for Arexvy?
The generic name for Arexvy is Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted. There are no other listed brand versions of Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted.
What is the NDC code for Arexvy ?
The NDC (National Drug Code) for Arexvy is 58160-894, listed by GlaxoSmithKline Biologicals SA.
Other Arexvy Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)